antibody
Washington (AFP) - A synthetic antibody developed by Eli Lilly reduced the risk of contracting Covid-19 by 80 percent in a study of nursing home residents when used preventatively, the company said Thursday. Though the result is only preliminary and awaiting peer review, the finding was hailed as highly promising by experts, who said it meant that the infused therapy had the potential to complement vaccines. "We are exceptionally pleased with these positive results, which showed bamlanivimab was able to help prevent COVID-19, substantially reducing symptomatic disease among nursing home reside...
AFP
Washington (AFP) - Scientists at the University of Pennsylvania and the biotech firm Regeneron are investigating whether technology developed for gene therapy can be used to make a nasal spray that will prevent infection with the new coronavirus. The idea is to use a weakened virus as a delivery truck to carry genetic instructions to cells within the nose and the throat, which will in turn create powerful antibodies to stop SARS-CoV-2 from invading our bodies. "The advantage of our approach is that you don't need a competent immune system for this to be effective," James Wilson, a professor of...
AFP
Washington (AFP) - Two US companies have applied for emergency approval for their lab-produced antibodies against Covid-19 -- and President Donald Trump has signaled his strong backing based on the fact he was treated with one of them.Here's what we know about the treatments and why the perception of political interference at the Food and Drug Administration may have eroded public trust.What are they? - The therapies developed by Regeneron and Eli Lilly are called "monoclonal antibodies," a relatively new class of drugs that are best known for treating certain types of cancer and autoimmune di...
AFP
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら